| Treatment of highly drug-resistant pulmonary tuberculosis F Conradie, AH Diacon, N Ngubane, P Howell, D Everitt, AM Crook, ... New England Journal of Medicine 382 (10), 893-902, 2020 | 744 | 2020 |
| Bedaquiline in the treatment of multidrug-and extensively drug-resistant tuberculosis AS Pym, AH Diacon, SJ Tang, F Conradie, M Danilovits, C Chuchottaworn, ... European Respiratory Journal 47 (2), 564-574, 2016 | 377 | 2016 |
| A trial of a shorter regimen for rifampin-resistant tuberculosis AJ Nunn, PPJ Phillips, SK Meredith, CY Chiang, F Conradie, D Dalai, ... New England Journal of Medicine 380 (13), 1201-1213, 2019 | 368 | 2019 |
| HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study RL Hamers, CL Wallis, C Kityo, M Siwale, K Mandaliya, F Conradie, ... The Lancet infectious diseases 11 (10), 750-759, 2011 | 343 | 2011 |
| Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial I Sanne, C Orrell, MP Fox, F Conradie, P Ive, J Zeinecker, M Cornell, ... The Lancet 376 (9734), 33-40, 2010 | 303 | 2010 |
| Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study K Schnippel, N Ndjeka, G Maartens, G Meintjes, I Master, N Ismail, ... The lancet respiratory medicine 6 (9), 699-706, 2018 | 268 | 2018 |
| Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma, P Hunidzarira, ... The Lancet 399 (10337), 1779-1789, 2022 | 240 | 2022 |
| Adult antiretroviral therapy guidelines 2017 G Meintjes, MA Moorhouse, S Carmona, N Davies, S Dlamini, ... Southern African journal of HIV medicine 18 (1), 1-24, 2017 | 235 | 2017 |
| Bedaquiline–pretomanid–linezolid regimens for drug-resistant tuberculosis F Conradie, TR Bagdasaryan, S Borisov, P Howell, L Mikiashvili, ... New England Journal of Medicine 387 (9), 810-823, 2022 | 204 | 2022 |
| Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis N Ndjeka, F Conradie, K Schnippel, J Hughes, N Bantubani, H Ferreira, ... The International Journal of Tuberculosis and Lung Disease 19 (8), 979-985, 2015 | 169 | 2015 |
| Antiretroviral therapies in women after single-dose nevirapine exposure S Lockman, MD Hughes, J McIntyre, Y Zheng, T Chipato, F Conradie, ... New England Journal of Medicine 363 (16), 1499-1509, 2010 | 150 | 2010 |
| Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a … CD Tweed, R Dawson, DA Burger, A Conradie, AM Crook, CM Mendel, ... The Lancet Respiratory Medicine 7 (12), 1048-1058, 2019 | 133 | 2019 |
| High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen N Ndjeka, K Schnippel, I Master, G Meintjes, G Maartens, R Romero, ... European Respiratory Journal 52 (6), 2018 | 117 | 2018 |
| Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection LG Bekker, K Rebe, F Venter, G Maartens, M Moorhouse, F Conradie, ... Southern African journal of HIV medicine 17 (1), 2016 | 104 | 2016 |
| Guideline on safer conception in fertile HIV-infected individuals and couples: guideline LG Bekker, V Black, L Myer, H Rees, D Cooper, S Mall, C Mnyami, ... Southern African Journal of HIV Medicine 12 (2), 31-44, 2011 | 104 | 2011 |
| Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor‐naive … K Ruxrungtham, RJ Pedro, GH Latiff, F Conradie, P Domingo, S Lupo, ... HIV medicine 9 (10), 883-896, 2008 | 94 | 2008 |
| QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial KE Dooley, SL Rosenkranz, F Conradie, L Moran, R Hafner, ... The Lancet Infectious Diseases 21 (7), 975-983, 2021 | 87 | 2021 |
| Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa K van der Merwe, MF Chersich, K Technau, Y Umurungi, F Conradie, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (5), 577-581, 2006 | 82 | 2006 |
| Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance—HIV drug resistance in sub-Saharan Africa and the Asia … RL Hamers, R Oyomopito, C Kityo, P Phanuphak, M Siwale, ... International journal of epidemiology 41 (1), 43-54, 2012 | 79 | 2012 |
| Guidelines for antiretroviral therapy in adults G Meintjes, G Maartens Southern African Journal of HIV Medicine 13 (3), 114-133, 2012 | 79 | 2012 |
